Global Medical REIT Inc. (NYSE:XRN – Get Free Report) announced a monthly dividend on Wednesday, May 6th. Stockholders of record on Monday, July 20th will be paid a dividend of 0.16 per share on Friday, August 14th. This represents a c) annualized dividend and a dividend yield of 6.5%. The ex-dividend date of this dividend is Monday, July 20th.
Global Medical REIT has decreased its dividend payment by an average of 0.0%per year over the last three years. Global Medical REIT has a payout ratio of 6,000.0% indicating that the company cannot currently cover its dividend with earnings alone and is relying on its balance sheet to cover its dividend payments.
Global Medical REIT Trading Down 16.7%
XRN stock traded down $5.95 during midday trading on Thursday, reaching $29.64. The company’s stock had a trading volume of 118,984 shares, compared to its average volume of 100,036. The business’s 50-day simple moving average is $35.24 and its 200-day simple moving average is $34.39. The company has a quick ratio of 0.61, a current ratio of 0.61 and a debt-to-equity ratio of 1.62. Global Medical REIT has a 52 week low of $29.05 and a 52 week high of $39.93. The stock has a market cap of $392.19 million, a PE ratio of -32.41 and a beta of 1.11.
Key Headlines Impacting Global Medical REIT
- Positive Sentiment: Company announced up to a $100 million delayed‑draw convertible perpetual preferred equity investment led by Maewyn Capital Partners, boosting liquidity and supporting Chiron/Global Medical’s repositioning and growth plans. Chiron Announces $100M Strategic Investment
- Positive Sentiment: Signed purchase agreements to acquire three seniors‑housing (SHOP) communities for an aggregate $425 million, increasing scale in higher‑return assets and keeping existing operators (Silverstone/Greystone) in place. This supports the company’s stated shift to growth‑oriented, higher‑return investments. Acquisition of SHOP Communities
- Positive Sentiment: Declared monthly dividends of $0.16 per share across upcoming months (annualized yield ~5.4%), reinforcing the REIT’s income profile and appealing to yield‑focused investors. (Multiple record/ex‑dividend dates announced for June–August distributions.)
- Neutral Sentiment: Reported Q1 results: $0.97 EPS and $38.06M revenue; management reiterated a repositioning strategy focused on recycling capital into higher‑ROIC investments (inaugural SHOP investments highlighted). The results show progress on strategy but also mixed profitability metrics. Q1 Press Release Financial Results Release
- Negative Sentiment: Compass Point reaffirmed a “neutral” rating but cut its price target from $50 to $38, signaling reduced upside expectations and likely contributing downward pressure on sentiment despite the company’s corporate actions. Analyst Note — Benzinga
Global Medical REIT Company Profile
Global Medical REIT (NYSE: GMRE) is a real estate investment trust focused on owning and managing healthcare-related properties across the United States. The company acquires, develops and leases a diversified portfolio of medical office buildings, outpatient facilities, long-term care centers and other specialized healthcare real estate. By concentrating on essential healthcare assets, Global Medical REIT seeks to generate stable, long-term rental income under triple-net and modified gross lease structures.
Since its incorporation in 2016 and initial public offering in 2017, the company has pursued an acquisitive growth strategy targeting markets with strong demographic trends and limited supply of modern medical facilities.
Recommended Stories
Receive News & Ratings for Global Medical REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Medical REIT and related companies with MarketBeat.com's FREE daily email newsletter.
